BANKCOMM(03328) completes issuance of 40 billion yuan perpetual capital bonds.
Bank of Communications (03328) announced that it has issued the "Bank of Communications Limited 2026 First Tranche Perpetual Bonds (Bond Connect)" in the national interbank bond market, and the issuance was completed on May 25, 2026. The issuance size of this bond is RMB 40 billion, with a fixed coupon rate of 1.94% for the first 5 years, which will be adjusted every 5 years. The issuer has the conditional redemption right starting from the 5th year and on each subsequent interest payment date. The proceeds from this bond issuance, after deducting issuance expenses, will be used to supplement the bank's other tier 1 capital in accordance with applicable laws and regulatory approvals.
BANKCOMM (03328) announced that it has issued the "BANKCOMM Limited Company 2026 First Tranche Perpetual Capital Bonds (Bond Connect)" in the national interbank bond market, and the issuance was completed on May 25, 2026. The size of this bond issuance is 40 billion yuan, with a fixed interest rate of 1.94% for the first 5 years, which will be adjusted every 5 years. The issuer has the conditional redemption right after the 5th year and on each interest payment date thereafter. The funds raised from this bond issuance, after deducting issuance expenses, will be used to supplement the bank's other tier one capital in accordance with applicable laws and regulatory approvals.
Related Articles
Zhejiang Jingsheng Mechanical & Electrical (300316.SZ) actual controller Qiu Minxiu plans to reduce its shareholding by no more than 0.73%.
HeiLongJiang ZBD Pharmaceutical (603567.SH) subsidiary will obtain the exclusive sales agency rights of TRS005, independently developed by Zhejiang Tersi, in China region.
Zhejiang Shibao (01057) A-shares stock trading abnormal fluctuations exist undisclosed information that should be disclosed but has not been disclosed
Zhejiang Jingsheng Mechanical & Electrical (300316.SZ) actual controller Qiu Minxiu plans to reduce its shareholding by no more than 0.73%.
HeiLongJiang ZBD Pharmaceutical (603567.SH) subsidiary will obtain the exclusive sales agency rights of TRS005, independently developed by Zhejiang Tersi, in China region.
Zhejiang Shibao (01057) A-shares stock trading abnormal fluctuations exist undisclosed information that should be disclosed but has not been disclosed
